Revance Therapeutics
Latest round
- Series E
Last raised
- Apr 2013
Total raised
- $168M
Investors
- 12
About Revance Therapeutics
Revance Therapeutics, Inc.Revance Therapeutics, Inc. focuses on the development of therapeutic and aesthetic products.00 mn.Revance Therapeutics, Inc. specializes in innovative aesthetics and skincare solutions, focusing on products that enhance both appearance and skin health for various age groups. The company's flagship offerings include DAXXIFY® (DaxibotulinumtoxinA-lanm), a peptide-formulated neuromodulator approved for the temporary improvement of moderate to severe glabellar lines and treatment of cervical dystonia in adults. Additionally, Revance markets the Teoxane RHA® Collection, which features hyaluronic acid fillers designed for treating dynamic facial lines and wrinkles through advanced Preserved Network Technology., and BIOJUVE®, which utilizes clinically proven living microbe technology.Revance generates revenue primarily through direct sales of its specialized aesthetic products and therapeutic solutions to healthcare professionals, clinics, and distributors.13 mn. The company employs a B2B model, supplying products like DAXXIFY® and the Teoxane RHA® Collection to aesthetic practices and dermatology clinics, which then offer these treatments to their end customers.Revance Therapeutics, Inc. has plans to introduce new products and expand into new markets.00 mn, Revance aims to launch additional products in the aesthetic space and explore opportunities for market entry in regions such as Asia-Pacific and Latin America, targeting the next few years to establish a presence in these growing markets.
Who invested in Revance Therapeutics
12 investors across 6 rounds
See all investors in Revance Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Revance Therapeutics
Who invested in Revance Therapeutics?
Revance Therapeutics has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Revance Therapeutics raised?
Revance Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Revance Therapeutics last raise money?
Revance Therapeutics's most recent round on record is a Series E, in Apr 2013.
What does Revance Therapeutics do?
Revance Therapeutics is a biotechnology company.
Where is Revance Therapeutics headquartered?
Revance Therapeutics is headquartered in Nashville, US.
Which VCs invest in companies like Revance Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Revance Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Revance Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.